Scoreformer: A Surrogate Model For Large-Scale Prediction of Docking Scores
In this study, we present ScoreFormer, a novel graph transformer model designed to accurately predict molecular docking scores, thereby optimizing high-throughput virtual screening (HTVS) in drug discovery. The architecture integrates Principal Neighborhood Aggregation (PNA) and Learnable Random Walk Positional Encodings (LRWPE), enhancing the model's ability to understand complex molecular structures and their relationship with their respective docking scores. This approach significantly surpasses traditional HTVS methods and recent Graph Neural Network (GNN) models in both recovery and efficiency due to a wider coverage of the chemical space and enhanced performance. Our results demonstrate that ScoreFormer achieves competitive performance in docking score prediction and offers a substantial 1.65-fold reduction in inference time compared to existing models. We evaluated ScoreFormer across multiple datasets under various conditions, confirming its robustness and reliability in identifying potential drug candidates rapidly.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoveryGraph Neural NetworkMolecular DockingMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Understanding active learning of molecular docking and its applications
With the advancing capabilities of computational methodologies and resources, ultra-large-scale virtual screening via molecular docking has emerged as a prominent strategy for in silico hit discovery. Given the exhaustiv…
Active LearningMolecular DockingProtein-Ligand Docking Surrogate Models: A SARS-CoV-2 Benchmark for Deep Learning Accelerated Virtual Screening
We propose a benchmark to study surrogate model accuracy for protein-ligand docking. We share a dataset consisting of 200 million 3D complex structures and 2D structure scores across a consistent set of 13 million "in-st…
GPUMFBind: a Multi-Fidelity Approach for Evaluating Drug Compounds in Practical Generative Modeling
Current generative models for drug discovery primarily use molecular docking to evaluate the quality of generated compounds. However, such models are often not useful in practice because even compounds with high docking …
Active LearningActivity PredictionDrug DiscoveryMolecular DockingDeep Surrogate Docking: Accelerating Automated Drug Discovery with Graph Neural Networks
The process of screening molecules for desirable properties is a key step in several applications, ranging from drug discovery to material design. During the process of drug discovery specifically, protein-ligand docking…
Drug DiscoveryMF-LAL: Drug Compound Generation Using Multi-Fidelity Latent Space Active Learning
Current generative models for drug discovery primarily use molecular docking as an oracle to guide the generation of active compounds. However, such models are often not useful in practice because even compounds with hig…
Active LearningActivity PredictionDrug DiscoveryMolecular Docking